Ecofibre Limited
Ecofibre Limited, together with its subsidiaries, engages in the polymer, health care, and hemp seed genetics businesses in the United States and Australia. The company operates through Ecofibre Advanced Technologies, Ananda Health, Ecofibre Genetics, and EOF Bio segments. It offers cannabinoid based health products for human and pet consumption. In addition, the company provides yarn, polymer te… Read more
Ecofibre Limited (EOFBF) - Net Assets
Latest net assets as of December 2024: $25.15 Million USD
Based on the latest financial reports, Ecofibre Limited (EOFBF) has net assets worth $25.15 Million USD as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($58.04 Million) and total liabilities ($32.89 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $25.15 Million |
| % of Total Assets | 43.33% |
| Annual Growth Rate | 60.09% |
| 5-Year Change | -34.97% |
| 10-Year Change | N/A |
| Growth Volatility | 925.04 |
Ecofibre Limited - Net Assets Trend (2016–2024)
This chart illustrates how Ecofibre Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Ecofibre Limited (2016–2024)
The table below shows the annual net assets of Ecofibre Limited from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-06-30 | $40.97 Million | -45.12% |
| 2023-06-30 | $74.65 Million | -32.10% |
| 2022-06-30 | $109.94 Million | -1.66% |
| 2021-06-30 | $111.80 Million | +77.45% |
| 2020-06-30 | $63.00 Million | +48.93% |
| 2019-06-30 | $42.30 Million | +2611.73% |
| 2018-06-30 | $1.56 Million | +298.32% |
| 2017-06-30 | $-786.60K | -182.84% |
| 2016-06-30 | $949.54K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Ecofibre Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 8455303200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $120.81 Million | 302.31% |
| Other Comprehensive Income | $9.93 Million | 24.86% |
| Total Equity | $39.96 Million | 100.00% |
Ecofibre Limited Competitors by Market Cap
The table below lists competitors of Ecofibre Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Golden Haven Memorial Park Inc
PSE:HVN
|
$379.16K |
|
Versant Media Group, Inc. Class A Common Stock When-Issued
NASDAQ:VSNT
|
$379.50K |
|
Xanadu Mines Limited
PINK:XANAF
|
$379.59K |
|
MOLSON COORS-B NVTG - Dusseldorf Stock Exchang
DU:NY7
|
$379.97K |
|
CORDIANT DIGITAL INFR.SUB
F:86L0
|
$378.38K |
|
Aviv Arlon Ltd
TA:AVLN
|
$378.28K |
|
TUGA Innovations Inc
PINK:TUGAF
|
$378.23K |
|
Lobe Sciences Ltd
OTCQB:LOBEF
|
$378.13K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ecofibre Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 74,630,000 to 39,963,000, a change of -34,667,000 (-46.5%).
- Net loss of 44,344,000 reduced equity.
- Share repurchases of 367,000 reduced equity.
- New share issuances of 10,854,000 increased equity.
- Other comprehensive income decreased equity by 14,076,000.
- Other factors increased equity by 13,266,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-44.34 Million | -110.96% |
| Share Repurchases | $367.00K | -0.92% |
| Share Issuances | $10.85 Million | +27.16% |
| Other Comprehensive Income | $-14.08 Million | -35.22% |
| Other Changes | $13.27 Million | +33.2% |
| Total Change | $- | -46.45% |
Book Value vs Market Value Analysis
This analysis compares Ecofibre Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.10x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 3.53x to 0.10x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-06-30 | $0.00 | $0.01 | x |
| 2017-06-30 | $0.00 | $0.01 | x |
| 2018-06-30 | $0.01 | $0.01 | x |
| 2019-06-30 | $0.15 | $0.01 | x |
| 2020-06-30 | $0.21 | $0.01 | x |
| 2021-06-30 | $0.35 | $0.01 | x |
| 2022-06-30 | $0.33 | $0.01 | x |
| 2023-06-30 | $0.22 | $0.01 | x |
| 2024-06-30 | $0.11 | $0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ecofibre Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -110.96%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -158.46%
- • Asset Turnover: 0.39x
- • Equity Multiplier: 1.78x
- Recent ROE (-110.96%) is below the historical average (-75.18%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 25.33% | 100.02% | 0.08x | 3.34x | $145.53K |
| 2017 | 0.00% | -1571.45% | 0.09x | 0.00x | $-8.57 Million |
| 2018 | -553.01% | -150.69% | 0.51x | 7.22x | $-8.78 Million |
| 2019 | 14.18% | 16.85% | 0.75x | 1.13x | $1.77 Million |
| 2020 | 20.88% | 25.94% | 0.60x | 1.34x | $6.86 Million |
| 2021 | -6.25% | -24.26% | 0.20x | 1.27x | $-18.17 Million |
| 2022 | -13.34% | -48.54% | 0.20x | 1.36x | $-25.66 Million |
| 2023 | -53.48% | -122.77% | 0.27x | 1.59x | $-47.38 Million |
| 2024 | -110.96% | -158.46% | 0.39x | 1.78x | $-48.34 Million |
Industry Comparison
This section compares Ecofibre Limited's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ecofibre Limited (EOFBF) | $25.15 Million | 25.33% | 1.31x | $378.87K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |